Literature DB >> 12667540

Facial expression recognition in people with medicated and unmedicated Parkinson's disease.

R Sprengelmeyer1, A W Young, K Mahn, U Schroeder, D Woitalla, T Büttner, W Kuhn, H Przuntek.   

Abstract

Recognition of facial expressions of emotion was investigated in people with medicated and unmedicated Parkinson's disease (PD) and matched controls (unmedicated PD, n=16; medicated PD, n=20; controls, n=40). Participants in the medicated group showed some visual impairment (impaired contrast sensitivity) and performed less well on perception of unfamiliar face identity, but did not show significant deficits in the perception of sex, gaze direction, or familiar identity from the face. For both Parkinson's disease groups, there was evidence of impaired recognition of facial expressions in comparison to controls. These deficits were more consistently noted in the unmedicated group, who were also found to perform worse than the medicated group at recognising disgust from prototypical facial expressions, and at recognising anger and disgust in computer-manipulated images. Although both Parkinson's disease groups showed impairments of facial expression recognition, the consistently worse recognition of disgust in the unmedicated group is consistent with the hypothesis from previous studies that brain regions modulated by dopaminergic neurons are involved in the recognition of disgust.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667540     DOI: 10.1016/s0028-3932(02)00295-6

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  72 in total

1.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

2.  Startle reflex hyporeactivity in Parkinson's disease: an emotion-specific or arousal-modulated deficit?

Authors:  K M Miller; M S Okun; M Marsiske; E B Fennell; D Bowers
Journal:  Neuropsychologia       Date:  2009-03-13       Impact factor: 3.139

3.  Increased anxiety-like behavior following circuit-specific catecholamine denervation in mice.

Authors:  Sara Ferrazzo; Ozge Gunduz-Cinar; Nadia Stefanova; Gabrielle A Pollack; Andrew Holmes; Claudia Schmuckermair; Francesco Ferraguti
Journal:  Neurobiol Dis       Date:  2019-01-21       Impact factor: 5.996

4.  Tone discrimination as a window into acoustic perceptual deficits in Parkinson's disease.

Authors:  Joshua Troche; Michelle S Troche; Rebecca Berkowitz; Murray Grossman; Jamie Reilly
Journal:  Am J Speech Lang Pathol       Date:  2012-03-21       Impact factor: 2.408

Review 5.  Parkinson's disease as a disconnection syndrome.

Authors:  Alice Cronin-Golomb
Journal:  Neuropsychol Rev       Date:  2010-04-10       Impact factor: 7.444

6.  Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV.

Authors:  Uraina S Clark; Keenan A Walker; Ronald A Cohen; Kathryn N Devlin; Anna M Folkers; Matthew J Pina; Karen T Tashima
Journal:  Neuropsychologia       Date:  2015-03-03       Impact factor: 3.139

7.  Recognition of emotions from visual and prosodic cues in Parkinson's disease.

Authors:  Alessandra Ariatti; Francesca Benuzzi; Paolo Nichelli
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

8.  Facial emotion recognition impairment in patients with Parkinson's disease and isolated apathy.

Authors:  Mercè Martínez-Corral; Javier Pagonabarraga; Gisela Llebaria; Berta Pascual-Sedano; Carmen García-Sánchez; Alexandre Gironell; Jaime Kulisevsky
Journal:  Parkinsons Dis       Date:  2010-07-28

9.  The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates.

Authors:  Patrick McNamara; Karina Stavitsky; Raymon Durso; Erica Harris
Journal:  Parkinsons Dis       Date:  2010-03-11

Review 10.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.